Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
480
datasets available to search
ShareScore release 0.7.1
Dataset results
480 results for “Hormone Receptors”
A Study Of Changes In PD-L1 Expression During Preoperative Treatment With Nab-Paclitaxel And Pembrolizumab In Hormone Receptor-Positive Breast Cancer
ClinicalTrials.gov study NCT02999477. IPD Sharing: NO. Countries: 1. Publications: 2.
A Study of Ipatasertib in Combination With Paclitaxel as a Treatment for Participants With PIK3CA/AKT1/PTEN-Altered, Locally Advanced or Metastatic, Triple-Negative Breast Cancer or Hormone Receptor-P
ClinicalTrials.gov study NCT03337724. IPD Sharing: Not stated. Countries: 30. Publications: 1.
Tucatinib, Palbociclib and Letrozole in Metastatic Hormone Receptor Positive and HER2-positive Breast Cancer
ClinicalTrials.gov study NCT03054363. IPD Sharing: NO. Countries: 1. Publications: 2.
Low-dose Oral Cyclophosphamide and Methotrexate Maintenance for Hormone Receptor-negative Early Breast Cancer
ClinicalTrials.gov study NCT00022516. IPD Sharing: Not stated. Countries: 11. Publications: 2.
Alternative Dosing Schedule of Palbociclib in Metastatic Hormone Receptor Positive Breast Cancer
ClinicalTrials.gov study NCT03007979. IPD Sharing: NO. Countries: 1. Publications: 1.
A Study of Pertuzumab in Combination With Trastuzumab Plus an Aromatase Inhibitor in Participants With Metastatic Human Epidermal Growth Factor Receptor 2 (HER2)-Positive and Hormone Receptor-Positive
ClinicalTrials.gov study NCT01491737. IPD Sharing: Not stated. Countries: 8. Publications: 1.
Corticotropin-Releasing Hormone Receptor 1 (CRH1) Antagonism in Anxious Alcoholics^
ClinicalTrials.gov study NCT01227980. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Study of Trastuzumab Deruxtecan (T-DXd) vs Investigator's Choice Chemotherapy in HER2-low, Hormone Receptor Positive, Metastatic Breast Cancer
ClinicalTrials.gov study NCT04494425. IPD Sharing: YES. Countries: 28. Publications: 2.
Pembrolizumab and Doxorubicin Hydrochloride or Anti-Estrogen Therapy in Treating Patients With Triple-Negative or Hormone Receptor-Positive Metastatic Breast Cancer
ClinicalTrials.gov study NCT02648477. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Randomized Phase II Study Of Eribulin Mesylate With or Without Pembrolizumab For Metastatic Hormone Receptor Positive Breast Cancer
ClinicalTrials.gov study NCT03051659. IPD Sharing: NO. Countries: 1. Publications: 2.
A Study of GDC-0810 Single Agent or in Combination With Palbociclib and/or a Luteinizing Hormone-Releasing Hormone (LHRH) Agonist in Women With Locally Advanced or Metastatic Estrogen Receptor Positiv
ClinicalTrials.gov study NCT01823835. IPD Sharing: Not stated. Countries: 4. Publications: 1.
QUILT-2.015: A Study of AMG 479 With Exemestane or Fulvestrant in Postmenopausal Women With Hormone Receptor Positive Locally Advanced or Metastatic Breast Cancer
ClinicalTrials.gov study NCT00626106. IPD Sharing: Not stated. Countries: 9. Publications: 1.
A Single Arm Phase II Study of ADjuvant Endocrine Therapy, Pertuzumab, and Trastuzumab for Patients With Anatomic Stage I Hormone Receptor-positive, HER2-positive Breast Cancer
ClinicalTrials.gov study NCT04569747. IPD Sharing: YES. Countries: 1. Publications: 1.
Exemestane With or Without Entinostat in Treating Patients With Recurrent Hormone Receptor-Positive Breast Cancer That is Locally Advanced or Metastatic
ClinicalTrials.gov study NCT02115282. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Study of Physiological and High Dose Estradiol in the Treatment of Hormone Receptor Positive Metastatic Breast Cancer
ClinicalTrials.gov study NCT00324259. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study Of Letrozole With Or Without Palbociclib (PD-0332991) For The First-Line Treatment Of Hormone-Receptor Positive Advanced Breast Cancer
ClinicalTrials.gov study NCT00721409. IPD Sharing: YES. Countries: 12. Publications: 8.
A Clinical Trial to Assess the Safety of 0.005 % Estriol Vaginal Gel in Hormone Receptor-Positive Postmenopausal Women With Early Stage Breast Cancer in Treatment With Aromatase Inhibitor in the Adjuv
ClinicalTrials.gov study NCT02413008. IPD Sharing: Not stated. Countries: 2. Publications: 1.
A Neoadjuvant Study of Abemaciclib (LY2835219) in Postmenopausal Women With Hormone Receptor Positive, HER2 Negative Breast Cancer
ClinicalTrials.gov study NCT02441946. IPD Sharing: YES. Countries: 10. Publications: 2.
Neoadjuvant Endocrine Therapy in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Node-Negative Breast Cancer
ClinicalTrials.gov study NCT03219476. IPD Sharing: NO. Countries: 1. Publications: 1.
A Study of Abemaciclib (LY2835219) Combined With Fulvestrant in Women With Hormone Receptor Positive HER2 Negative Breast Cancer
ClinicalTrials.gov study NCT02107703. IPD Sharing: YES. Countries: 20. Publications: 5.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.